PRDS Live signals | Maximize Profits with Getagraph.com

Live Chart Being Loaded With Signals

Commentary (30 Aug 2023 @ 15:59):

Stats
Today's Volume	2.15M
Average Volume	509 687
Market Cap	135.19M
EPS	$0 ( 2024-03-12 )
Next earnings date	( $0 ) 2024-05-03
Last Dividend	$0 ( N/A )
Next Dividend	$0 ( N/A )
P/E	-1.703
ATR14	$0.0440 (2.04%)

Insider Trading

Date	Person	Action	Amount	type
2023-08-31	Tananbaum James B.	Buy	1 000	Common Stock
2023-08-31	Tananbaum James B.	Buy	37 500	Stock Option (Right to Buy)
2023-08-31	Tananbaum James B.	Buy	37 500	Stock Option (Right to Buy)
2023-08-31	Tananbaum James B.	Sell	16 813 146	Common Stock
2023-08-31	Tananbaum James B.	Buy	75 000	Stock Option (Right to Buy)

INSIDER POWER
-76.06
Last 97 transactions
Buy: 18 682 185 \| Sell: 33 827 653

Volume Correlation

Long: 0.31 (neutral)

Short: 0.00 (neutral)

Signal:(70.026) Neutral

Pardes Biosciences, Inc. Correlation

10 Most Positive Correlations
DCGO	0.914
APOP	0.884
DRCT	0.882
BYFC	0.867
CEVA	0.859
ANPC	0.853
AIRS	0.851
DMTK	0.85
RMRM	0.849
DGHI	0.849

10 Most Negative Correlations
MGTA	-0.887
MMAC	-0.849
LUCD	-0.849
TWNK	-0.834
POLA	-0.823
PATI	-0.821
SOPA	-0.819
MFNC	-0.816
HMNF	-0.809
JAN	-0.808

Did You Know?

Correlation is a statistical measure that describes the relationship between two variables. It ranges from -1 to 1, where -1 indicates a perfect negative correlation (as one variable increases, the other decreases), 1 indicates a perfect positive correlation (as one variable increases, the other increases), and 0 indicates no correlation (there is no relationship between the variables).

Correlation can be used to analyze the relationship between any two variables, not just stocks. It's commonly used in fields such as finance, economics, psychology, and more.

Pardes Biosciences, Inc. Correlation - Currency/Commodity

0.76
( moderate )

0.36
( neutral )

0.00
( neutral )

-0.77
( moderate negative )

0.19
( neutral )

-0.09
( neutral )

Pardes Biosciences, Inc. Financials

Annual	2022
Revenue:	$0
Gross Profit:	$0 (0.00 %)
EPS:	$-1.610

Q2	2023
Revenue:	$0
Gross Profit:	$0 (0.00 %)
EPS:	$-0.180

Q1	2023
Revenue:	$0
Gross Profit:	$0 (0.00 %)
EPS:	$-0.240

Q4	2022
Revenue:	$0
Gross Profit:	$0 (0.00 %)
EPS:	$-0.840

Financial Reports:

No articles found.

Pardes Biosciences, Inc.

Pardes Biosciences, Inc., a clinical stage biopharmaceutical company, focuses on discovering, developing, and commercializing novel therapeutics to improve the lives of patients suffering from life-threatening disease. Its lead candidate is the PBI-0451 that is in clinical development stage to treat and prevent severe acute respiratory syndrome coronavirus 2 infections and associated diseases. The company was incorporated in 2020 and is headquartered in Carlsbad, California.